Literature DB >> 11263978

Distribution of cellular isoform of prion protein in T lymphocytes and bone marrow, analyzed by wild-type and prion protein gene-deficient mice.

A Kubosaki1, S Yusa, Y Nasu, T Nishimura, Y Nakamura, K Saeki, Y Matsumoto, S Itohara, T Onodera.   

Abstract

In this study, the authors investigated normal cellular prion protein (PrP(C)) expression on murine immune systems using prion protein gene-deficient mouse as negative control. Immunocytes expressing PrP(C) in adult and fetal mice were detected by flow cytometry with the monoclonal antibody against PrP(C), 6H4. Cells from thymus and bone marrow reacted positively with 6H4, while spleen cells, peritoneal cells, peripheral blood leukocytes, and intestinal intraepithelial lymphocytes were nonreactive. In thymus, PrP(C) was observed in CD4(-)CD8(-) double-negative thymocytes. PrP(C+) cells of double-negative thymocytes belonged to the CD3(-) subset, but not to the CD3(+) subset. Triple-negative PrP(C+) thymocytes expressed CD44 or CD25 antigens. Furthermore, PrP(C) was observed in c-kit(+) bone marrow cells. In fetuses, PrP(C+) cells were observed in the liver and thymus at day 16.0 and 15.0 of gestation, respectively. These results demonstrated that PrP(C) is expressed on immature immunocytes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263978     DOI: 10.1006/bbrc.2001.4538

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.

Authors:  Laura McCulloch; Karen L Brown; Neil A Mabbott
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

2.  Enhanced susceptibility of T lymphocytes to oxidative stress in the absence of the cellular prion protein.

Authors:  Catherine Aude-Garcia; Christian Villiers; Serge M Candéias; Catherine Garrel; Caroline Bertrand; Véronique Collin; Patrice N Marche; Evelyne Jouvin-Marche
Journal:  Cell Mol Life Sci       Date:  2010-08-18       Impact factor: 9.261

3.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

Review 4.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.

Authors:  Jeremy D Isaacs; Oliver A Garden; Gurman Kaur; John Collinge; Graham S Jackson; Daniel M Altmann
Journal:  Immunology       Date:  2008-05-06       Impact factor: 7.397

6.  Quantitative and qualitative analysis of cellular prion protein (PrP(C)) expression in bovine somatic tissues.

Authors:  Oscar A Peralta; Willard H Eyestone
Journal:  Prion       Date:  2009-07-07       Impact factor: 3.931

Review 7.  The role of the cellular prion protein in the immune system.

Authors:  J D Isaacs; G S Jackson; D M Altmann
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 8.  Prion disease and the innate immune system.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

9.  Cellular distribution of the prion protein in palatine tonsils of mule deer (Odocoileus hemionus) and Rocky Mountain elk (Cervus elaphus nelsoni).

Authors:  Matthew M Hille; Jean E Jewell; E Lee Belden
Journal:  J Vet Med Sci       Date:  2019-09-24       Impact factor: 1.267

Review 10.  Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Authors:  Stefano Thellung; Alessandro Corsaro; Alessia G Bosio; Martina Zambito; Federica Barbieri; Michele Mazzanti; Tullio Florio
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.